|
--- |
|
license: apache-2.0 |
|
language: |
|
- pt |
|
--- |
|
# Skin Cancer Image Classification Model |
|
|
|
## Introduction |
|
|
|
This model is designed for the classification of skin cancer images into various categories including benign keratosis-like lesions, basal cell carcinoma, actinic keratoses, vascular lesions, melanocytic nevi, melanoma, and dermatofibroma. |
|
|
|
## Model Overview |
|
|
|
- Model Architecture: Vision Transformer (ViT) |
|
- Pre-trained Model: Google's ViT with 16x16 patch size and trained on ImageNet21k dataset |
|
- Modified Classification Head: The classification head has been replaced to adapt the model to the skin cancer classification task. |
|
|
|
## Dataset |
|
|
|
- Dataset Name: Skin Cancer Dataset |
|
- Source: [Marmal88's Skin Cancer Dataset on Hugging Face](https://huggingface.co/datasets/marmal88/skin_cancer) |
|
- Classes: Benign keratosis-like lesions, Basal cell carcinoma, Actinic keratoses, Vascular lesions, Melanocytic nevi, Melanoma, Dermatofibroma |
|
|
|
## Training |
|
|
|
- Optimizer: Adam optimizer with a learning rate of 1e-4 |
|
- Loss Function: Cross-Entropy Loss |
|
- Batch Size: 32 |
|
- Number of Epochs: 5 |
|
|
|
## Evaluation Metrics |
|
|
|
- Train Loss: Average loss over the training dataset |
|
- Train Accuracy: Accuracy over the training dataset |
|
- Validation Loss: Average loss over the validation dataset |
|
- Validation Accuracy: Accuracy over the validation dataset |
|
|
|
## Results |
|
|
|
- Epoch 1/5, Train Loss: 0.7168, Train Accuracy: 0.7586, Val Loss: 0.4994, Val Accuracy: 0.8355 |
|
- Epoch 2/5, Train Loss: 0.4550, Train Accuracy: 0.8466, Val Loss: 0.3237, Val Accuracy: 0.8973 |
|
- Epoch 3/5, Train Loss: 0.2959, Train Accuracy: 0.9028, Val Loss: 0.1790, Val Accuracy: 0.9530 |
|
- Epoch 4/5, Train Loss: 0.1595, Train Accuracy: 0.9482, Val Loss: 0.1498, Val Accuracy: 0.9555 |
|
- Epoch 5/5, Train Loss: 0.1208, Train Accuracy: 0.9614, Val Loss: 0.1000, Val Accuracy: 0.9695 |
|
## Conclusion |
|
|
|
The model demonstrates good performance in classifying skin cancer images into various categories. Further fine-tuning or experimentation may improve performance on this task. |